F&P Healthcare's In-Line Outlook Reassures Investors

Fisher & Paykel Healthcare's FY27 Outlook Reassures Forsyth Barr

Breathing-tech provider Fisher & Paykel Healthcare's FY27 outlook has reassured analysts at Forsyth Barr. The company signaled that revenue trends are likely to be similar to FY26, with the exception of moderating hardware growth.

Cost Headwinds and Margin Target

Analyst Ben Crozier noted that while higher freight and input costs create a headwind, this is offset by lower tariff impact and continued underlying margin improvements. As a result, F&P Healthcare's 65% long-term gross margin target appears achievable.

Forsyth Barr believes this allows investors to look through a large portion of additional headwinds and retains a neutral call on the stock. Shares were up 0.3% at NZ$37.72.